Glooko’s mission is to help simplify collaboration and optimize health outcomes for people with diabetes and their clinicians by bringing relevant data together. Specifically, the company’s software platforms empower diabetes management by collecting and unlocking the power of data from blood-glucose meters, CGMs, insulin pumps, pens, and activity trackers. Glooko’s technology allows for the convenient aggregation of disparate data which ultimately allows health care specialists to collaborate and treat patients more confidently. The company’s platforms are compatible with the vast majority of diabetes devices available giving people with diabetes and their care teams freedom of choice.
Health Catalyst Capital led a $30 million financing in March 2021 via a senior convertible preferred investment and has a designee on the board of directors. We are excited about the opportunity to work collaboratively with Glooko’s senior management to help execute the value creation plan.
Learn more at https://www.glooko.com